Centogene N.V.

CNTG · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenue$48,536$47,473$42,234$38,453
% Growth2.2%12.4%9.8%
Cost of Goods Sold$31,287$27,554$27,668$35,286
Gross Profit$17,249$19,919$14,566$3,167
% Margin35.5%42%34.5%8.2%
R&D Expenses$12,361$17,488$19,297$14,935
G&A Expenses$29,173$29,206$43,480$37,665
SG&A Expenses$41,737$39,130$52,806$45,245
Sales & Mktg Exp.$12,564$9,924$9,326$7,580
Other Operating Expenses-$7,190-$84$0$0
Operating Expenses$46,908$56,534$72,977$60,180
Operating Income-$29,659-$36,773-$55,488-$53,731
% Margin-61.1%-77.5%-131.4%-139.7%
Other Income/Exp. Net-$5,586-$1,823-$1,934-$6,083
Pre-Tax Income-$35,245-$38,596-$57,422-$59,814
Tax Expense$287$107-$70$224
Net Income-$35,532-$31,841-$46,246-$21,378
% Margin-73.2%-67.1%-109.5%-55.6%
EPS-1.27-1.11-2.09-1.02
% Growth-14.4%46.9%-104.9%
EPS Diluted-1.26-1.11-2.09-1.02
Weighted Avg Shares Out28,16326,81122,43720,910
Weighted Avg Shares Out Dil28,16326,81122,43720,910
Supplemental Information
Interest Income$205$3$3$25
Interest Expense$8,201$3,571$802$1,038
Depreciation & Amortization$7,610$10,378$19,974$15,128
EBITDA-$19,434-$24,647-$36,646-$43,667
% Margin-40%-51.9%-86.8%-113.6%